IRVINE, Calif.--(BUSINESS WIRE)--Cenomed BioSciences, LLC, a privately-held biopharmaceutical company focused on the development of innovative new drug therapies for the treatment of nervous system disorders, today announced that David R. Helton, president and chief scientific officer, will present a company overview at the SoCalBio Investor Conference (Southern California Biomedical Council) on June 7, 2007 at the Wilshire Grand Hotel, Downtown Los Angeles, California.
